Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder [Phase 1]
A Phase 1 study in COPD patients evaluated safety, tolerability, and pharmacokinetics after single inhaled doses of ciprofloxacin (50 mg and…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B [Phase 3]
Phase 3 trial update for a dual bronchodilator treatment in COPD patients; study completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection [Phase 4]
Phase 4 study evaluating tiotropium 18 mcg in chronic obstructive pulmonary disease patients with a concurrent respiratory infection; result…
-
CLINICAL_TRIALS trial_result · 2014-04-03Clinical Trial Update: Patient -Ventilator Interaction in Chronic Respiratory Failure [Phase 2]
Phase 2 trial update reporting completion of a study on patient-ventilator interaction in chronic respiratory failure, including chronic hyp…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III) [Phase 1]
Phase 1 trial update evaluating safety, tolerability, pulmonary deposition, and pharmacokinetics/pharmacodynamics of inhaled ciprofloxacin i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]
Phase 1 study to evaluate safety and pharmacokinetics of inhaled ciprofloxacin in patients with moderate to severe chronic obstructive pulmo…
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: The Effect of Statins in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
A Phase 4 clinical trial evaluating the effect of statins in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: A 52-Week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Tolerability of GSK573719/GW642444 and GSK573719 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 randomized, double-blind trial in chronic obstructive pulmonary disease evaluated the safety and tolerability of GSK573719/GW64244…
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects [Phase 1]
Phase 1 study evaluating the effect of GS-5737 on mucociliary clearance in healthy subjects; the trial sponsored by Gilead Sciences has been…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients [Phase 1]
A Phase 1 safety, pharmacokinetic and pharmacodynamic study of PUR0200 in COPD patients has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Long-term Safety Study for GSK573719/GW642444 in Japanese [Phase 3]
A long-term safety study of the COPD drug GSK573719/GW642444 in Japanese patients has completed Phase 3, and results were posted in March 20…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Chinese Community Smoking Cessation Project [NA]
A completed clinical trial update for a UCSF-sponsored smoking cessation project conducted in China, listing cardiovascular diseases, heart …
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Endothelial Dysfunction in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
A completed clinical trial sponsored by the Ludwig Boltzmann Institute studied endothelial dysfunction during acute exacerbations of chronic…
-
CLINICAL_TRIALS trial_result · 2014-03-12Clinical Trial Update: Early Telemedicine Training in Patients With COPD [NA]
A completed clinical trial evaluating early telemedicine training for patients with Chronic Obstructive Pulmonary Disease (COPD).
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Severe Chronic Obstructive Pulmonary Disease Inhalation Profiles Comparison [Phase 1]
Phase 1 trial completed comparing inhalation profiles for chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: Does Muscle Wasting Always Mean Muscle Weakness? A Prevalence Study in COPD
This completed clinical trial update investigates the prevalence of muscle wasting in COPD and its association with muscle weakness.
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Single Portable Pulse-dose-conserving Device vs. Combined Use of Stationary and Portable. [Phase 3]
Phase 3 trial comparing a single portable pulse-dose-conserving device against a combined stationary and portable setup for chronic obstruct…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Balance Training for Chronic Obstructive Pulmonary Disease (COPD)
A completed clinical trial update evaluating balance training for chronic obstructive pulmonary disease (COPD).
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: A Study to Assess the Efficacy of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25 mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50 mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing once-daily fluticasone furoate/vilanterol (100/25 mcg) to twice-daily fluticasone propionate/salmeterol (250/50 mcg)…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease [Phase 2]
GlaxoSmithKline completed a Phase 2 dose-ranging study of GSK573719 in chronic obstructive pulmonary disease; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD [Phase 3]
A 24-week Phase 3 trial evaluating GSK573719/vilanterol and components in COPD has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase 3 trial comparing DISKUS and ELLIPTA inhaler devices for patients with chronic obstructive pulmonary disease completed, with results…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: 14729-D9831C00002- 1 Month Biopsy Study [Phase 2]
A Phase 2 COPD trial (1-month biopsy study) sponsored by AstraZeneca has completed, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension. [Phase 1]
A Phase 1 single-dose study in patients with COPD-associated pulmonary hypertension has completed, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: NOWOX Oxygen Therapy Monitoring Device [NA]
The NOWOX Oxygen Therapy Monitoring Device trial conducted by Air Liquide SA for Chronic Obstructive Pulmonary Disease has completed.